Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
Go back to Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service| StemCells, Inc. (NASDAQ: TEM) | Delayed: 78.45 +0.42 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.03 | 52 Week High | $0.45 | |||
| Open | $77.99 | 52 Week Low | $0.37 | |||
| Day High | $79.00 | P/E | N/A | |||
| Day Low | $75.81 | EPS | $-0.31 | |||
| Volume | 2,546,215 | |||||
